Marcus Ruhlmann

572 total citations
23 papers, 388 citations indexed

About

Marcus Ruhlmann is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Marcus Ruhlmann has authored 23 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Marcus Ruhlmann's work include Thyroid Cancer Diagnosis and Treatment (14 papers), Radiomics and Machine Learning in Medical Imaging (8 papers) and Medical Imaging Techniques and Applications (8 papers). Marcus Ruhlmann is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (14 papers), Radiomics and Machine Learning in Medical Imaging (8 papers) and Medical Imaging Techniques and Applications (8 papers). Marcus Ruhlmann collaborates with scholars based in Germany, Netherlands and Italy. Marcus Ruhlmann's co-authors include Walter Jentzen, Andreas Bockisch, Verena Ruhlmann, Ina Binse, A. Bockisch, Michael Forsting, Sandra Rosenbaum‐Krumme, Gerald Antoch, James Nagarajah and Rainer Görges and has published in prestigious journals such as PLoS ONE, Journal of Nuclear Medicine and Journal of Magnetic Resonance Imaging.

In The Last Decade

Marcus Ruhlmann

23 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcus Ruhlmann Germany	11	271	151	91	60	55	23	388
Francesca Soldà United Kingdom	8	94 0.3×	107 0.7×	99 1.1×	162 2.7×	14 0.3×	13	372
K. Brandt-Mainz Germany	7	241 0.9×	383 2.5×	192 2.1×	47 0.8×	15 0.3×	17	526
Francesca Capoccetti Italy	12	242 0.9×	215 1.4×	141 1.5×	68 1.1×	5 0.1×	20	461
Péter Ágoston Hungary	9	103 0.4×	83 0.5×	135 1.5×	109 1.8×	16 0.3×	29	444
Ulrich Feine Germany	6	156 0.6×	208 1.4×	161 1.8×	38 0.6×	9 0.2×	9	377
Ryan Neff United States	4	89 0.3×	105 0.7×	76 0.8×	81 1.4×	4 0.1×	6	318
Jakob W. Kist Netherlands	11	107 0.4×	186 1.2×	147 1.6×	50 0.8×	6 0.1×	18	457
Jiro Kawamori Japan	13	114 0.4×	16 0.1×	97 1.1×	93 1.6×	27 0.5×	50	369
Zhining Yang China	10	100 0.4×	38 0.3×	103 1.1×	74 1.2×	111 2.0×	23	320
Comron Hassanzadeh United States	10	80 0.3×	20 0.1×	71 0.8×	132 2.2×	24 0.4×	22	305

Countries citing papers authored by Marcus Ruhlmann

Since Specialization

Citations

This map shows the geographic impact of Marcus Ruhlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Ruhlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Ruhlmann more than expected).

Fields of papers citing papers by Marcus Ruhlmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Ruhlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Ruhlmann. The network helps show where Marcus Ruhlmann may publish in the future.

Co-authorship network of co-authors of Marcus Ruhlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Ruhlmann. A scholar is included among the top collaborators of Marcus Ruhlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Ruhlmann. Marcus Ruhlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruhlmann, Marcus, Wilfried Sonnenschein, James Nagarajah, et al.. (2018). Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities. Nuclear Medicine Communications. 39(5). 457–464. 5 indexed citations

Ruhlmann, Marcus, J. Ruhlmann, Rainer Görges, et al.. (2017). ¹⁸ F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography May Exclude Malignancy in Sonographically Suspicious and Scintigraphically Hypofunctional Thyroid Nodules and Reduce Unnecessary Thyroid Surgeries. Thyroid. 27(10). 1300–1306. 5 indexed citations

Ruhlmann, Marcus, et al.. (2016). Initiale [18F]FDG-PET/CT bei Hochrisikopatienten mit differenziertem Schilddrüsenkarzinom. Nuklearmedizin - NuclearMedicine. 55(3). 99–103. 5 indexed citations

Ruhlmann, Verena, Thorsten D. Poeppel, Alexander Sascha Brandt, et al.. (2016). 18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease. European Journal of Nuclear Medicine and Molecular Imaging. 43(9). 1646–1652. 10 indexed citations

Ruhlmann, Marcus, Walter Jentzen, Verena Ruhlmann, et al.. (2016). High Level of Agreement Between Pretherapeutic ¹²⁴I PET and Intratherapeutic ¹³¹I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases. Journal of Nuclear Medicine. 57(9). 1339–1342. 32 indexed citations

Binse, Ina, Thorsten D. Poeppel, Marcus Ruhlmann, et al.. (2016). ⁶⁸Ga-DOTATOC PET/CT in Patients with Iodine- and ¹⁸F-FDG–Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin. Journal of Nuclear Medicine. 57(10). 1512–1517. 25 indexed citations

Theysohn, Jens, Marcus Ruhlmann, Stefan Müller, et al.. (2015). Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?. PLoS ONE. 10(9). e0137587–e0137587. 8 indexed citations

Jentzen, Walter, Andreas Bockisch, & Marcus Ruhlmann. (2015). Assessment of Simplified Blood Dose Protocols for the Estimation of the Maximum Tolerable Activity in Thyroid Cancer Patients Undergoing Radioiodine Therapy Using ¹²⁴I. Journal of Nuclear Medicine. 56(6). 832–838. 25 indexed citations

Schelhorn, Juliane, Jan Best, Guido Gerken, et al.. (2015). Therapy Response Assessment after Radioembolization of Patients with Hepatocellular Carcinoma—Comparison of MR Imaging with Gadolinium Ethoxybenzyl Diethylenetriamine Penta-Acetic Acid and Gadobutrol. Journal of Vascular and Interventional Radiology. 26(7). 972–979. 5 indexed citations

10.

Beiderwellen, Karsten, Marcus Ruhlmann, Daniel H. Paulus, et al.. (2015). Impact of Point-Spread Function Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging. Journal of Nuclear Medicine. 57(1). 78–84. 18 indexed citations

11.

Jentzen, Walter, et al.. (2015). Niedrigste effektive Radioiodaktivität zur Ablation des Schilddrüsenrestes bei Patienten mit differenziertem Schilddrüsenkarzinom. Nuklearmedizin - NuclearMedicine. 54(3). 137–143. 9 indexed citations

12.

Binse, Ina, Thorsten D. Poeppel, Marcus Ruhlmann, et al.. (2015). Imaging with 124I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?. European Journal of Nuclear Medicine and Molecular Imaging. 43(6). 1011–1017. 22 indexed citations

13.

Schaarschmidt, Benedikt M., Philipp Heusch, Christian Buchbender, et al.. (2015). Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging. 43(1). 92–102. 78 indexed citations

14.

Ruhlmann, Marcus, et al.. (2015). Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Nuklearmedizin - NuclearMedicine. 54(3). 137–143. 10 indexed citations

15.

Ruhlmann, Marcus, et al.. (2014). Diagnostik hyperfunktioneller Schilddrüsenknoten. Nuklearmedizin - NuclearMedicine. 53(5). 173–177. 9 indexed citations

16.

Görges, Rainer, et al.. (2014). Diagnosis of hyperfunctional thyroidn odules. Nuklearmedizin - NuclearMedicine. 53(5). 173–177. 12 indexed citations

17.

Schelhorn, Juliane, Jan Best, Alexander Dechêne, et al.. (2014). Does diffusion‐weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd‐EOB‐DTPA with and without DWI. Journal of Magnetic Resonance Imaging. 42(3). 818–827. 11 indexed citations

18.

Nagarajah, James, et al.. (2012). 124I-PET/CT-Bildgebung bei Patienten mit Schilddrüsenkarzinomen – Unterscheidung zwischen Schilddrüsenrest und Lymphknotenmetastasen durch kinetische Größen. Nuklearmedizin - NuclearMedicine. 51(6). 213–216. 8 indexed citations

19.

Hartung-Knemeyer, Verena, James Nagarajah, Walter Jentzen, et al.. (2012). Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies. Annals of Nuclear Medicine. 26(9). 723–729. 15 indexed citations

20.

Nagarajah, James, et al.. (2012). 124I-PET/CT images of differentiated thyroid cancer patients. Nuklearmedizin - NuclearMedicine. 51(6). 213–216. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact